Literature DB >> 21565971

The RNA-binding protein Sam68 is a multifunctional player in human cancer.

Pamela Bielli1, Roberta Busà, Maria Paola Paronetto, Claudio Sette.   

Abstract

Src associated in mitosis, of 68 kDa (Sam68) is a KH domain RNA-binding protein that belongs to the signal transduction and activation of RNA family. Although ubiquitously expressed, Sam68 plays very specialized roles in different cellular environments. In most cells, Sam68 resides in the nucleus and is involved in several steps of mRNA processing, from transcription, to alternative splicing, to nuclear export. In addition, Sam68 translocates to the cytoplasm upon cell stimulation, cell cycle transitions or viral infections, where it takes part to signaling complexes and associates with the mRNA translation machinery. Recent evidence has linked Sam68 function to the onset and progression of endocrine tumors, such as prostate and breast carcinomas. Notably, all the biochemical activities reported for Sam68 seem to be implicated in carcinogenesis. Herein, we review the recent advancement in the knowledge of Sam68 function and regulation and discuss it in the frame of its participation to neoplastic transformation and tumor progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21565971     DOI: 10.1530/ERC-11-0041

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  78 in total

1.  Clinical significance of Sam68 expression in endometrial carcinoma.

Authors:  Qingying Wang; Yue Li; Jianhong Zhou; Jie Liu; Jinlong Qin; Feng Xing; Jiawen Zhang; Jiajing Cheng
Journal:  Tumour Biol       Date:  2015-01-21

Review 2.  Fragile X-associated tremor/ataxia syndrome (FXTAS): pathology and mechanisms.

Authors:  Paul Hagerman
Journal:  Acta Neuropathol       Date:  2013-06-21       Impact factor: 17.088

3.  Inhibition of Sam68 triggers adipose tissue browning.

Authors:  Junlan Zhou; Min Cheng; Chan Boriboun; Mariam M Ardehali; Changfei Jiang; Qinghua Liu; Shuling Han; David A Goukassian; Yao-Liang Tang; Ting C Zhao; Ming Zhao; Lu Cai; Stéphane Richard; Raj Kishore; Gangjian Qin
Journal:  J Endocrinol       Date:  2015-05-01       Impact factor: 4.286

4.  Cancer-Associated Mutations in Breast Tumor Kinase/PTK6 Differentially Affect Enzyme Activity and Substrate Recognition.

Authors:  Tiffany Tsui; W Todd Miller
Journal:  Biochemistry       Date:  2015-05-13       Impact factor: 3.162

5.  Hsp22 (HspB8/H11) knockdown induces Sam68 expression and stimulates proliferation of glioblastoma cells.

Authors:  Suhasini Modem; Kannagi Chinnakannu; Uma Bai; G Prem-Veer Reddy; Thipparthi R Reddy
Journal:  J Cell Physiol       Date:  2011-11       Impact factor: 6.384

6.  Expression of Sam68 Associates with Neuronal Apoptosis and Reactive Astrocytes After Spinal Cord Injury.

Authors:  Xinlei Chen; Lei Liu; Rong Qian; Jie Liu; Yu Yao; Zhenhuan Jiang; Xinjian Song; Jianbing Ren; Feng Zhang
Journal:  Cell Mol Neurobiol       Date:  2016-05-28       Impact factor: 5.046

Review 7.  Fragile X-associated tremor/ataxia syndrome.

Authors:  Paul J Hagerman; Randi J Hagerman
Journal:  Ann N Y Acad Sci       Date:  2015-01-26       Impact factor: 5.691

8.  High Sam68 expression predicts poor prognosis in non-small cell lung cancer.

Authors:  Z Zhang; Y Xu; N Sun; M Zhang; J Xie; Z Jiang
Journal:  Clin Transl Oncol       Date:  2014-02-13       Impact factor: 3.405

Review 9.  Faulty RNA splicing: consequences and therapeutic opportunities in brain and muscle disorders.

Authors:  Vittoria Pagliarini; Piergiorgio La Rosa; Claudio Sette
Journal:  Hum Genet       Date:  2017-04-22       Impact factor: 4.132

10.  TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.

Authors:  Charles A S Banks; Gina Boanca; Zachary T Lee; Cassandra G Eubanks; Gaye L Hattem; Allison Peak; Lauren E Weems; Juliana J Conkright; Laurence Florens; Michael P Washburn
Journal:  Mol Cell Proteomics       Date:  2016-09-08       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.